CORV Stock

In a note to clients on Monday, Mackie Research analyst André Uddin changed his rating on Correvio ... Read More

Recent share price weakness makes for a buying opportunity on Correvio Pharma (Correvio Pharma News,... Read More

Mackie Research analyst André Uddin is sticking to his guns when it comes to specialty pharmaceutic... Read More

After a volatile year in 2018, specialty pharma company Correvio Pharma (Correvio Pharma Stock Quote... Read More

Specialty pharma company Correvio Pharma (Correvio Pharma Corp. Stock Quote, Chart, News: TSX, NASDA... Read More